Studies

  1. Pregnant women with IBD drug safety

  2. Mirikizumab phase 2 trial in UC

  3. Low FODMAP trial on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease

  4. Pregnancy safety of antiTNF and vedolizumab

  5. 2º antiTNF +/- Azathioprine in IBD patients who had immune mediated LOR to first antiTNF

  6. Adalimumab originator vs biosimilar in CD